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Abstract 
Protein quality control is a balance between chaperone-assisted folding and removal of misfolded proteins 
from the ER. Cell-based assays have been used to identify key players of the dislocation machinery, 
including members of the Derlin family. We generated a conditional knockout mouse to examine the in 
vivo role of Derlin-2, a component that nucleates cellular dislocation machinery. In most Derlin-2 
deficient tissues, we found constitutive upregulation of ER chaperones and IRE-1 mediated induction of 
the unfolded protein response. The IRE-1/XBP-1 pathway is required for development of highly secretory 
cells, particularly plasma cells and hepatocytes. However, B lymphocyte development and antibody 
secretion were normal in the absence of Derlin-2. Likewise, hepatocyte function was unaffected by liver-
specific deletion of Derlin-2. Whole body deletion of Derlin-2 results in perinatal death. The few mice 
that survive to adulthood all developed skeletal dysplasia, likely caused by defects in collagen matrix 
protein secretion by costal chondrocytes. 
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Introduction 
 
Protein quality control is important: accumulation of misfolded proteins can cause a variety of 
diseases such as cystic fibrosis, Alzheimer’s disease, and spinocerebellar ataxia (1). Protein quality 
control occurs in all subcellular compartments where misfolded proteins arise or accumulate (cytosol, ER, 
lysosomes, etc.). In the example of cystic fibrosis, CFTR, a protein critical for chloride transport, is 
inactivated by mutations that impair its proper folding. In other cases, accumulation of mutant protein into 
amyloid aggregates causes disease. Amyloid-induced toxicities are common causes of neurodegenerative 
diseases such as Parkinson’s, Alzheimer’s and Huntington’s disease. For each of the known protein 
quality control diseases, a specific misfolded protein has been identified as the causative agent (1). One 
might therefore assume that more global defects in protein folding would also lead to pathologies, yet this 
hypothesis has been difficult to test. 
Protein quality control in the ER is achieved through chaperone-assisted folding and by removal 
of terminally misfolded proteins for destruction via the ubiquitin-proteasome system (2, 3). Folding status 
is monitored by a large variety of chaperones, and folding itself is regulated by chaperones as well. 
Misfolded glycoproteins may be recognized by calnexin and calreticulin which bind to monoglucosylated 
N-linked glycans. Protein disulphide isomerase (PDI) catalyzes the oxidation and reduction of disulphide 
bonds and also recognizes non-native structures. The importance of chaperones in the ER is underscored 
by the fact that genetic loss of most ER chaperones causes embryonic lethality (3). 
If proteins that enter the ER fail to fold properly, they must be removed from the ER, often in a 
process called dislocation (2). How misfolded proteins are recognized is not completely understood. 
Proteins with N-linked glycans may be  recognized by members of the EDEM protein family which 
enhance dislocation of certain misfolded proteins (4). The lectin domain-containing OS-9 protein also 
binds to alternate mannose-containing isomers, as well as to some misfolded proteins that lack N-linked 
glycans. OS-9 interacts directly with HRD-1 and Sel1L, a ubiquitin ligase complex that interacts with 
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Derlin 1 and Derlin 2 (5, 6). The Derlin family proteins contain four transmembrane domains and are 
thought to oligomerize in the ER lipid bilayer and may contribute to the formation of a dislocation pore 
(7-9). Misfolded proteins are extracted through the action of the cytosolic p97 AAA-ATPase which binds 
to the Derlins through the adaptor protein VIMP (8, 10). Attachment of at least one ubiquitin moiety is 
required for recognition by p97, although the ubiquitin is removed prior to full extraction from the ER (8, 
10). Several E3 ubiquitin ligases and deubiquitinating (DUBs) enzymes have been implicated in 
dislocation of misfolded proteins; among these are Ubc6e and YOD1 (5, 11).  
 Cells respond to misfolded proteins via three arms of the unfolded protein response (UPR) (12). 
PERK, ATF6 and IRE-1 are transmembrane proteins that reside in the ER, functionally coupled to ER 
quality control machinery. Accumulation of misfolded proteins in the ER can trigger each of these three 
UPR sensors by as yet poorly defined mechanisms. Activation of PERK results in phosphorylation of 
eIF2, which causes attenuation of protein synthesis (13). Paradoxically, the ATF4 mRNA, which 
encodes a transcription factor, is translated better under these circumstances. Increased ATF4 levels lead 
to transcriptional activation of several ER chaperones, genes involved in amino acid metabolism and 
transport, and CHOP (14). The second UPR sensor, ATF6, is found in the ER and interacts with BiP 
through its luminal domain. Dissociation from BiP exposes a Golgi localization sequence in ATF6, and 
once in the Golgi, ATF6 is cleaved by site-1 and site-2 proteases to release the 50 kDa active form of the 
ATF6 transcription factor, which then translocates to the nucleus (15). ATF6 activates transcription of 
BiP, XBP-1, various components of ER quality control and CHOP.  IRE-1, evolutionarily the most 
ancient of the ER stress sensors, is activated upon dimerization and autophosphorylation (16, 17). The 
cytoplasmic domain of IRE-1 catalyzes an unconventional RNA splicing event to remove a short 
sequence from XBP-1 mRNA (18). The resulting spliced XBP-1 protein (XBP-1s) translocates to the 
nucleus and activates transcription of ER chaperones and enzymes involved in lipid biosynthesis to allow 
expansion of the ER (19). 
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Knockout mice exist for all three arms of the UPR. Perk
-/-
 mice are born at Mendelian ratios, but 
show defects in both the endocrine and exocrine pancreas. They develop overt diabetes by 4 weeks of age 
(20). Accumulation of misfolded proteins can be observed directly in Perk
-/-
 pancreatic islet and acinar 
cells by electron microscopy, which shows distended, electron dense ER structures (20). Two Atf6 genes, 
Atf6 and Atf6 are present in mammals, and these have some functional redundancy. Atf6-/- mice are 
phenotypically normal, but develop liver steatosis upon  intraperitoneal challenge with tunicamycin (21). 
The combined Atf6/ double knockout is lethal at a stage prior to embryonic day 8.5, possibly due to an 
inability to transcribe genes that encode critical ER chaperones such as BiP (22). Indeed, Bip
-/-
 mice also 
die at an early stage of embryonic development (23). Both Ire-1-/- and Xbp1-/- mice die around 
embryonic day 13.5 due to liver failure (24). IRE-1 is expressed primarily in intestinal epithelial cells, 
and deletion of Ire1 renders mice susceptible to sodium dextran sulphate-mediated colitis (25). 
Conditional ablation of Xbp1 in B cells or in intestinal epithelial cells uncovered an essential requirement 
for XBP-1 in formation of plasma cells and Paneth cells, respectively (26, 27). Although XBP-1 induction 
in B cells occurs independently of unfolded protein accumulation, XBP-1 plays an important role in 
plasma cell formation through modulation of lipid synthesis, regulation of transcription factor expression 
and homing of plasma cells to the bone marrow (28, 29).  
 Blocking any of the three arms of the unfolded protein response should lead to an increase in 
misfolded proteins in tissues that are likely to experience ER stress because of a high secretory load. Loss 
of PERK, ATF6 and IRE-1 pathways primarily affects organs such as the liver and pancreas, as well as 
specific secretory cell types such as B cells and Paneth cells. Although all arms of the UPR cause 
upregulation of BiP and other ER chaperones, the majority of transcriptional targets for ATF4, ATF6 and 
XBP-1s are non-overlapping (30, 31). Furthermore, different tissues rely on the different UPR 
components to different extents. As a consequence, Perk
-/-
, Atf6
-/-
 and Ire1
-/-
 mice have quite different 
phenotypes. In general, however, disruption of any single branch of the UPR has serious adverse 
consequences. 
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 Here we report a knockout mouse model of a protein involved in ER dislocation. Derlin-2 
interacts with Derlin-1, Sel1L, VIMP, p97, HRD-1, OS-9 and Ubc6e to form a dislocation complex 
involved in the removal of misfolded substrates from the ER (5, 6, 8). Derlin-2 appears to be more 
abundant and is present at a higher level than Derlin-1 in the Sel1L-nucleated dislocation complex. 
Silencing of Derlin-2 impairs dislocation of the Null Hong Kong version of 1-antitrypsin (32). We show 
that the Derlin-2 deficient mouse displays constitutive activation of the UPR, and we demonstrate further 
an unexpected role for Derlin-2 in cartilage formation.  
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Results 
 
Derlin-2 conditional knockout mouse confirms a role for Derlin-2 in ER dislocation. 
 To study the role of Derlin-2 in different tissues, we generated a conditional knockout mouse in 
which the Derlin-2 gene is flanked by loxp sites (Supplemental Figure 1). The resulting Derlin-2 flox/flox 
mouse was crossed to mice expressing cre recombinase driven by the CMV promoter, by the CD19 
promoter or by the albumin promoter. The resulting Der2
-/-
, Der2
CD19
 and Der2
Alb
 mice have Derlin-2 
deleted in all tissues, in B cells or in hepatocytes, respectively. 
Previous work implicating the Derlins in removal of misfolded proteins from the ER has relied on 
RNA silencing or overexpression of dominant negative Derlin proteins (7-9). To show by genetic means 
that Derlin-2 is involved in ER dislocation, we generated mouse embryonic fibroblasts (MEFs) from 
embryonic day 13.5 Derlin-2 deficient fetuses or their wildtype littermates. Der2
-/- 
MEFs were then 
transfected with plasmids expressing ribophorin fragment (RI332) or the Null Hong Kong variant of 1-
antitrypsin (NHK). Both RI332 and NHK failed to be dislocated at normal rates in Der2
-/-
 MEFs, as 
shown by ER retention during pulse chase analysis (Figures 1A and 1B). On the other hand, we found no 
evidence for a systemic defect in the secretory pathway, since properly folded secretory or membrane 
proteins traverse the ER normally, as shown by equivalent secretion of wild type 1-antitrypsin and equal 
maturation of class I MHC (Figures 1B and 1C). 
  
Der2 -/- MEFs upregulate members of the dislocation complex and have a constitutive UPR. 
 Lysates from two independent wild type MEF lines (lanes 1, 2) and four independent Der2
-/-
MEF 
lines (lanes 3-6) were immunoblotted for various ER resident proteins and proteins involved in the UPR 
(Figure 2A). Sel1L, HRD-1, OS-9 and Ubc6e, all members of the Derlin dislocation complex, were 
upregulated in Der2
-/-
MEFs. This compensatory upregulation did not apply to Derlin-1; Derlin-1 protein 
levels were decreased in the absence of Derlin-2 despite increased levels of Derlin-1 transcripts (Figure 
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2A and data not shown), suggesting that the loss of Derlin-2 destabilizes Derlin-1 but not other known 
components of the dislocation complex. 
 IRE-1, XBP-1s, BiP and GRP94 were upregulated in Der2-/-MEFs, indicating induction of the 
UPR (Figure 2A). Although the UPR can proceed through three pathways in eukaryotes, the IRE-1 axis 
seemed to be the only pathway induced in Der2
-/-
MEFs. ATF-6 was not increased (data not shown), and 
elongation factor 2- (eIF2) phosphorylation was not increased, suggesting that the PERK pathway for 
UPR induction was not induced by the absence of Derlin-2. 
 MEF lysates were compared in a side-by-side analysis with lysates from naïve B cells, liver and 
chondrocytes (derived from wild type or Der2
CD19
, Der2
Alb
 or Der2
-/-
, respectively). In all tissues 
analyzed, Derlin-1 protein levels were decreased in Derlin-2 deficient cells (Figure 2B). OS-9 and Sel1L 
were strongly upregulated in Der2
-/-
 MEFs and chondrocytes, but were affected to a lesser degree in B 
cells and liver, underscoring the cell and tissue type-specific aspects of the UPR (Figure 2B). 
 
Loss of Derlin-2 in B lymphocytes has no effect on B cell development or antibody secretion. 
 Der2
CD19
 mice were born at normal Mendelian ratios as expected (data not shown). We were 
particularly interested in the B cell compartment, because IRE-1 deficiency affects B cell development 
(33). B cell subset analysis showed no defects in the percentage or total number of follicular, marginal 
zone, B-1, transitional T1 or T2, germinal center B cells or plasma cells (Figure 3A and Supplemental 
Table 1) in Der2
CD19
 mice: developing B cells in the bone marrow showed normal percentages of pro, pre 
and immature B cell populations (Supplemental Table 1). 
 Upon antigen engagement, naïve B cells develop into antibody-secreting cells and eventually into 
long-lived plasma cells which continue to secrete antibodies for the remainder of the organism’s life. The 
early stages of this process can be replicated in vitro by addition of lipopolysaccharide (LPS), which 
converts naïve B cells into antibody-secreting B cell blasts. The high rates of immunoglobulin secretion 
place extreme demands on the functional capacity of the ER. We therefore chose this model as a likely 
9 
 
cell type that might reveal even slight perturbations in quality control in the secretory pathway, as has 
been demonstrated for 1-antitrypsin in fibroblasts. However, metabolic labeling of Der2CD19 LPS blasts 
showed no defects in the rates of antibody production or secretion (Figures 3B and 3C). 
 Consistent with the apparent lack of effect of Derlin-2 in B cell development and function, 
immunoblotting of B cell lysates at various stages of LPS stimulation showed little differences in ER 
chaperones or dislocation complex members (Figure 3D), with the exception of Derlin-1, which showed a 
decrease similar to that seen in MEFs (Figure 2A and 2B). Neither IRE-1 nor XBP-1 protein levels were 
increased in Der2CD19 LPS blasts. Loss of Derlin-2 does not obviously enhance UPR activation in 
developing B cell blasts. By comparison, XBP-1 deficient LPS blasts, which are known to have defects in 
antibody secretion, show strong upregulation of IRE-1(Figure 3D) (28). 
 
Loss of Derlin-2 in hepatocytes has negligible effect on liver function despite an ongoing UPR. 
 Der2
Alb
 mice were also born at normal Mendelian ratios (data not shown). No differences were 
found in serum glucose or serum triglycerides in either fasting (Figures 4A and 4B) or fed mice (data not 
shown). Atf6-/- and Chop-/- mice show mild phenotypes at baseline, but rapidly succumb to severe liver 
or kidney disease when challenged with moderate amounts of tunicamycin to induce the unfolded protein 
response (21, 34). Der2
Alb
 mice and their wild type littermates were injected intraperitoneally with 
tunicamycin and sacrificed when their body weights reached 80% of baseline. Der2
Alb
 mice succumbed at 
the same rate as control mice (Figure 4C). Hepatocytes secrete the majority of serum proteins. We 
therefore assayed various serum protein levels as a measure of liver secretory function. Der2
Alb
 mice 
showed no signs of anemia (spun hematocrit levels: Der2
Alb
 = 48.2 +/- 2.0; littermate controls = 46.0 +/- 
2.0) and had normal levels of serum transferrin (Figure 4D). The levels of 1-antitrypsin were likewise 
unaffected (Figure 4D) and a functional assay for inhibition of elastase activity showed no difference 
(Figure 4E) between wild type and Der2
Alb
 mice.  Total serum albumin was also comparable between 
Der2
Alb
 and control mice (data not shown). 
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 Hepatocyte function is tightly linked to nutrient status; thus hepatocyte lysates were prepared 
from mice that had been fasted for 24 hours and mice that had been fed ad libitum (Figure 4F). Under 
starvation conditions, normal hepatocytes express less Derlin-2 protein (Figure 4F). As in MEFs, 
members of the Derlin dislocation complex Sel1L, HRD-1 and Ubc6e showed compensatory upregulation 
in the absence of Derlin-2. OS-9, which was upregulated more than 10-fold in MEFs, was unaffected in 
Derlin-2 deficient hepatocytes. Different tissues must therefore adapt to loss of Derlin-2 in different ways 
(Figures 2B and 4G). Der2
Alb
 hepatocytes showed increases in IRE-1and XBP-1s, both of which were 
somewhat attenuated by starvation. Thus, hepatocytes in Der2
Alb
 mice have an ongoing UPR, which is 
modified only slightly by the nutrient status of the mice (Figure 4F). 
 Hepatocytes were isolated from Der2
Alb
 mice or their wild type littermates and cultured ex vivo 
on collagen-coated plates. Metabolic labeling of these primary hepatocyte cultures showed no obvious 
differences in the profiles of intracellular (Figure 5A) or secreted proteins (Figure 5B). Apolipoprotein B 
is one of the largest proteins synthesized by hepatocytes and is regulated not only by stop transfer 
sequences that induce ribosome pausing, but also by p97-mediated ER dislocation (35, 36). Pulse chase 
analysis of apolipoprotein B (apoB-48) showed no differences in the rate of synthesis or secretion of 
apoB-48 particles or their associated albumin (Figures 5C and 5D). 
 
Whole body deletion of Derlin-2 leads to perinatal lethality and skeletal abnormalities. 
 To achieve complete deletion of Derlin-2, we crossed Derlin-2 flox/flox mice to mice transgenic 
for Cre driven by the CMV promoter. After one generation, the resulting mice were heterozygous for one 
deleted Derlin-2 allele and one wild type Derlin-2 allele. These mice were then intercrossed and should 
have yielded Derlin-2 deleted/deleted pups at 25% frequency. However, Der2
-/-
 mice represented only 4% 
of mice at weaning (n = 160). Genotyping of embryos at embryonic day 17.5-18.5 showed normal 
Mendalian inheritance, and no obvious abnormalities were observed in the Der2
-/-
  embryos. Closer 
inspection of Der2
-/-
  containing litters revealed several dead or dying pups 24 hours after birth, and 
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genotyping of 1 day old mice with inclusion of the dead or dying pups showed Der2
-/-
 mice to be 23.7% 
of the total. Thus, Der2
-/-
 pups are born at Mendelian ratios, but the majority dies within 24 hours of birth. 
 To determine the cause of death, several litters containing Der2
-/-
  pups were delivered by 
caesarean section. All pups breathed normally and were not cyanotic, suggesting that lung abnormalities 
and neural innervation of the diaphragm were not causes of death. Histological analysis of one-day old 
Der2
-/-
 pups showed no obvious cause of death, and serial sections of the heart showed no abnormalities 
(data not shown). The gross structures of the central and peripheral nervous systems and the formation of 
neuromuscular synapse formation were examined in Der2
-/-
 pups and found to be normal (Supplemental 
Figure 2). All neonatal mice are hypoglycemic; Der2
-/-
 mice that had been delivered via caesarean section 
and deprived of food showed no evidence of increased hypoglycemia at two hours post-birth (Figure 6A). 
Der2
-/-
 mice that were delivered vaginally and left with their mothers refused to feed. Der2
-/-
 pups 
consistently lacked milkspots and later died of starvation (Figure 6B). Hand-feeding of Der2
-/-
 pups 
showed that milk could reach the stomach, ruling out structural abnormalities in the upper digestive tract 
(data not shown). Fostering Der2
-/-
  pups to other lactating dams or removal of their wildtype littermates 
to decrease competition for food did not increase the survival rate of Der2
-/-
 pups (data not shown). We 
conclude that Der2
-/-
 pups die perinatally from a failure to feed, with the rare exceptions described below. 
 Der2
-/-
  mice show massive perinatal death, yet four percent of Der2
-/-
 mice from heterozygous 
crosses do survive to adulthood. Male Der2
-/-
 mice were sterile, despite having normal sperm production 
as assessed by PAS staining of testes (data not shown). Female Der2
-/-
 mice were capable of becoming 
pregnant, but 3 of 3 pregnancies ended in late-stage abortions requiring euthanasia of the mother. Thus all 
Der2
-/-
 mice studied here were generated by intercrosses of heterozygotes. The few surviving Der2
-/-
  
mice appeared healthy, although they were consistently smaller than their littermates  as measured by 
body weight (Figure 6C) and skeletal length (Der2
-/-
 = 8.9 +/- 0.40 cm; littermates = 9.9 +/- 0.42 cm; p < 
0.00001). Between 2 and 4 months of age, the surviving Der2
-/-
 mice developed a striking involution of 
the rib cage readily detectable by palpation. This involution became progressively worse with age, 
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causing hunching and breathing difficulties due to reduced lung volume. Aged Der2
-/-
 mice also 
developed a wasting disease, likely due to their poor overall health status and reduced ability to obtain 
food. By 12 months of age, all Der2
-/-
 mice had to be euthanized. 
 Skeletons from adult Der2
-/-
 mice stained with alizarin red and alcian blue showed normal bone 
and joint formation with the singular exception of the costal cartilage. Der2
-/-
 mice display fusion of the 
third and fourth sternebrae and develop linear calcifications perpendicular to the axis of rib and periodic 
nodular thickenings (Figure 6D). To determine when cartilage abnormalities first appeared, skeletal 
preparations were made from embryonic day 18.5 fetuses. By day 18.5 of gestation, wild type mice 
showed clear divisions of all sternebrae; however, the third and fourth sternebrae showed slightly delayed 
separation in Der2
-/-
 mice (Figure 6E). No rib abnormalities could be detected in fetal or in one day old 
Der2
-/-
 mice. Thus, defects in cartilage formation are mild at birth and grow progressively worse over 
time. Given the progressive nature of cartilage defects and the lack of internal hemorrhage in Der2
-/-
 pups, 
we conclude that cartilage defects are unlikely to account for the acute perinatal lethality observed in 
Der2
-/-
 mice. Histological evaluation of adult Der2
-/-
  ribs showed a defect in cartilage structure with 
abnormal chondrocytes (Figure 6F). In addition, many Der2
-/-
 chondrocytes contained eosinophilic 
cytoplasmic inclusions, suggesting a defect in protein secretion or degradation (Figure 6G). 
 
Derlin-2 deficient chondrocytes show intracellular retention of extracellular matrix components. 
 The skeletal defects in Der2
-/-
 mice phenocopy those of a mouse transgenic for mutant collagen 
oligomeric matrix protein (COMP) (37). COMP mutations in humans lead to either pseudoachondroplasia 
or multiple epiphyseal dysplasia, diseases marked by short stature and weakened cartilage (38, 39). 
Secreted COMP normally forms pentamers and, along with collagen IX and matrilin-3, binds to collagen 
II fibrils. In chondrocytes that express mutant COMP, the intracellularly retained COMP nucleates 
collagen II fibrils in the ER, causing ER dilation, upregulation of CHOP and ultimately death of the 
chondrocyte (37). Analysis of Der2
-/-
 chondrocytes by electron microscopy likewise revealed ER dilations 
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consistent with intracellular retention of collagen matrix proteins (Figure 7A and 7B). These ER dilations 
were observed in Der2
-/-
 chondrocytes that had been grown in three-dimensional culture for 1 day or 8 
days (Figure 7B). After 18 days of culture, virtually all Der2
-/-
  chondrocytes were dead, while wild type 
chondrocytes were still viable (data not shown). To determine whether ER stress was related to the 
increase in chondrocyte death, we analyzed expression of CHOP, an apoptosis-inducing protein that is a 
downstream target of the unfolded protein response. CHOP upregulation was observed in chondrocytes 
that had been cultured for 8 days (Figure 7C). CHOP transcripts were also upregulated in primary 
chondrocytes isolated freshly from embryonic day 18.5 Der2
-/-
 sternums as well as in cultured 
chondrocytes (Figure 7D), suggesting an increase in chondrocyte apoptosis in vivo, and not simply a cell 
culture effect. Both Der2
-/-
  and wild type chondrocyte cultures contained collagen fibrils, and no 
differences in fibril length or diameter were observed by EM (Supplemental Figure 4). Thus, Der2
-/-
  
chondrocytes are capable of at least some collagen secretion while alive, which is consistent with the 
mild, progressive nature of the structural abnormalities seen in Der2
-/-
 mice. We therefore conclude that 
skeletal defects observed in Der2
-/-
 mice are most likely the result of abnormal ER retention of collagen 
matrix proteins and a consequent increase in chondrocyte apoptosis. 
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Discussion 
  
 The normal pathways of protein quality control may be compromised either by a reduction in 
protein folding capability, or by the failure to remove misfolded proteins from the ER. Genetic ablation of 
ER chaperones is often lethal (3). Genetic deletion of some of the known components of the dislocon 
would be expected to lead to a blockade in dislocation or to a failure to remove proteins from the ER. The 
Derlin family of proteins provides an attractive target for such attempts at interference, since they have 
not been linked to any normal cellular functions other than ER dislocation. We chose to generate a Derlin-
2 conditional knockout mouse because Derlin-2 is ubiquitously expressed and is the strongest interacting 
partner of the ER-resident ubiquitin ligase HRD1/Sel1L. 
 Der2
-/-
  MEFs show impaired dislocation of the misfolded substrates RI332 and NHK, in 
accordance with data obtained using a dominant negative version of Derlin-2 and shRNA approaches to 
knock down expression of Der2.  Der2
-/-
 MEFs showed strong induction of UPR components, implying 
the accumulation of misfolded proteins in these cells, although we have yet to determine the identity of 
candidate misfolded proteins in these MEFs. However, the extent to which induction of the UPR is 
caused by accumulation of misfolded proteins or is engaged by other malfunctions in the ER is not easily 
ascertained. With the exception of B cells, all Der2
-/-
 cell types and tissues examined showed tonic 
induction of the UPR, with tissue-specific differences in the upregulation of the various components. 
Known members of the dislocation complex showed compensatory upregulation in Der2
-/-
 cells. Sel1L, 
HRD-1 and Ubc6e levels were elevated in almost every cell type examined. OS-9 levels were higher in 
Der2
-/-
 MEFs and chondrocytes, but showed little expression in hepatocytes or B cells. Derlin-1, which is 
known to form hetero-oligomeric complexes with Derlin-2 (8), was downregulated in Der2
-/-
  cells. 
Derlin1/2 complexes may form the transmembrane pore through which misfolded substrates traverse the 
ER bilayer (7, 9). In the absence of Derlin-2, Derlin-1 channels may be less stable, leading to decreased 
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Derlin-1 protein levels in these cells. In the absence of Derlin-2, misfolded proteins become trapped in the 
ER and so induce the unfolded protein response. 
 The physiological consequences of a constitutively active UPR have not been addressed 
previously. In most tissues, a tonic UPR has no obvious adverse consequences. Cells of the B lymphocyte 
lineage, including plasma cells which apparently are among the most highly active secretory cells in the 
body, are unaffected by loss of Derlin-2. Hepatocytes, another highly active secretory cell type, are 
similarly unaffected by the absence of Derlin-2. Der2
-/- 
MEFs survive in tissue culture without overt signs 
of distress. A tonic increase in expression of proteins associated with dislocation is apparently required by 
Der2
-/-
 cells to thrive. How exactly these upregulated proteins contribute to homeostasis remains to be 
explored in detail. Contrary to expectations, Der2
-/-
  mice are born at Mendelian ratios and die perinatally 
from a failure to feed. How protein quality control could be related to a failure to feed is currently 
unclear. Nonetheless, Derlin-2 is not required for survival, since roughly one fifth of the expected Der2
-/-
 
mice from heterozygous crosses reach adulthood. The few surviving Der2
-/-
 mice are normal in most 
respects, despite having a tonic UPR in all tissues. In fact, the only cells obviously affected by absence of 
Derlin-2 were costal cartilage chondrocytes.  These results illustrate the remarkable homeostatic 
regulation exerted over protein quality control.  
What could cause the observed cartilage defect in Der2
-/-
 mice? Chondrocytes express Derlin-2 at 
a level similar to that seen in most other tissues, and although Derlin-1 levels are reduced in Der2
-/-
 
chondrocytes, Derlin-1 is not altogether absent. Chondrocytes are highly active secretory cells, but why 
other cells with an equally high secretory burden should be unaffected by loss of Derlin-2 is not 
immediately obvious. One possible explanation is that collagen matrix proteins are exquisitely sensitive 
to errors in protein folding. Knockout mice for COMP or matrilin-3 have virtually no phenotype, yet mice 
transgenic for point mutations in these same proteins develop skeletal displasias (37, 40-42). Small 
amounts of misfolded collagen matrix proteins can lead to huge deposits of fibrillar collagen in the ER, 
and cause decreased collagen secretion, culminating in death of the affected chondrocytes. Perk
-/-
 mice 
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develop skeletal abnormalities due to inadequate secretion of collagen I by osteoblasts, a cell type that 
expresses unusually high levels of PERK. Dense granules, presumably composed of collagen fibrils, 
accumulate in the ER of Perk
-/-
 osteoblasts (43). Thus we speculate that Der2
-/-
 chondrocytes accumulate 
extracellular matrix proteins in the ER, leading to distension of the ER and death of the affected 
chondrocytes. The progressive loss of chondrocytes with age would explain the progressive nature of the 
cartilage defects in Der2
-/-
 mice. 
To our knowledge, the Der2
-/-
 mouse is the first example of a viable mouse uniquely deficient in a 
component involved in protein dislocation. A Sel1L deficient mouse has been reported which is 
embryonic lethal around E day 13.5 due to brain and liver abnormalities (44, 45); similarly, loss of HRD-
1 results in lethality at E day 13.5 due to failure of hematopoiesis in the fetal liver (46). However the lack 
of viable pups and the fact that Sel1L plays regulatory role in Notch signaling complicate the use of these 
models for studying the role of dislocation in a whole organism. Although whole body deletion of Derlin-
2 results in perinatal lethality with few animals surviving to adulthood, conditional deletion of Derlin-2 
will allow further study of the role of protein dislocation in particular organs or tissues of interest. 
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Methods 
 
Animals: Derlin-2 floxed animals were generated by conventional gene targeting as illustrated in 
Supplemental Figure 1. Derlin-2 floxed mice were intercrossed with CD19cre+, Albcre+ or CMVcre+ 
transgenic mice (Jackson labs) to generate Der2
CD19
, Der2
Alb
  and Der2
-/-
 mice, respectively. All animals 
were housed at the Whitehead Institute for Biomedical Research, and were maintained according to 
guidelines approved by the MIT Committee on Animal Care. 
 
Metabolic labeling and pulse chase experiments: Cells were starved in methionine- and cysteine-free 
medium containing dialyzed serum for 1 hr,
 
then pulse-labeled for 20 min (unless otherwise indicated) 
with 250 µCi/ml of [
35
S]-methionine and [
35
S]-cysteine (PerkinElmer).
  
At the
 
end of each chase interval, 
cells were lysed in radioimmunoprecipitation
 
assay buffer containing protease inhibitors. Lysates were 
then
 
analyzed by immunoprecipitation, SDS-PAGE, and fluorography.
 
Band intensity was determined 
using a phosphor imager (Fujifilm
 
BAS 2500), and quantitation was done using the MultiGauge software
 
(Fujifilm). HA agarose beads (Roche) or primary antibodies to 1-antitrypsin (Novus Biologicals), MHC 
class I (p8), IgM (Southern Biotechnology
 
Associates), or Apolipoprotein B (Lifespan Biosciences) 
combined with Protein G sepharose (Sigma) were used for immunoprecipitations. 
 
Antibodies, reagents and immunoblotting: Cell lysates were prepared using conventional RIPA buffer 
supplemented with protease inhibitors (Calbiochem). Lysates were clarified at 16,000g for 10 min at 4C, 
resolved by SDS-PAGE (10% acrylamide) and electrophoretically transferred onto a nitrocellulose 
membrane, which was then blocked with 5% non-fat milk in PBS-T (PBS containing 0.05% Tween 20, 
pH 7.4) before incubation with a primary antibody. After incubating with horseradish peroxidase (HRP)-
conjugated secondary antibody (SouthernBiotech), the PBS-T washed membrane was developed using the 
Western Lightning
TM
 Chemiluminescence Reagent PLUS system (PerkinElmer). The following 
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commercial antibodies were used for immunoblotting: XBP-1 (Santa Cruz), IRE-1  (Cell Signaling), 
eIF2  (Cell Signaling), actin (Sigma), calreticulin (Stressgen), p97 (Fitzgerald), OS-9 (Novus 
Biologicals), HRD-1 (Novus Biologicals), GRP94 (Stressgen), calnexin (Stressgen), 1-antitrypsin 
(Novus Biologicals), transferrin (Novus Biologicals), MTP (BD), CHOP (Santa Cruz). Antibodies to 
Derlin-1, Derlin-2, Sel1L, BiP, Ubc6e and PDI were generated in our laboratory. 
 
Flow cytometry: The following antibodies for flow cytometry were obtained from BD Pharmingen: IgM 
(11/41 or R6-60.2), IgD (11-26c.2a), CD1d (1B1), CD19 (MB19-1), CD23 (B3B4), CD43 (1B11), 
CD138 (281-2), B220 (RA3-6B2), AA4.1 and GL7. Live B cells were stained with the indicated Abs and 
analyzed
 
by a FACSCalibur flow cytometer (BD Biosciences). Data were
 
analyzed using CellQuest (BD 
Biosciences). 
 
Cell culture: Mouse embryonic fibroblasts were prepared by dissection and mechanical disruption of 
embryonic day 14.5 fetuses obtained from pregnant Der2
+/-
 females mated to Der2
+/-
 males. Livers and 
hearts were removed and the remaining carcass pieces were digested overnight in 0.02% trypsin at 4
o
C. 
The tissue pellet was then resuspended in DMEM containing 10% fetal calf serum and plated into 10cm 
tissue culture dishes. Individual embryos were genotyped, and all experiments using wild type and Der2
-/-
  
MEFs were performed using MEFs derived from the same litter. Naïve B lymphocytes were purified from 
mouse spleen by magnetic depletion of CD43-positive cells (Miltenyi Biotech). Naïve B cells were 
cultured in RPMI 1640 media containing 10% FBS with or without LPS (20 g/ml). Primary hepatocytes 
were isolated and cultured from Der2
Alb
  mice or their cre-negative littermates. Briefly, mice were 
anesthetized
 
with an intraperitoneal injection of ketamine (87 mg/kg body
 
wt; Webster Veterinary, 
Sterling, MA, USA) plus xylazine (13
 
mg/kg body wt; Webster Veterinary). Thereafter, the inferior
 
vena 
cava was exposed, cannulated, and perfused for 5 min with
 
liver perfusion media (Invitrogen), followed 
by a 10 min perfusion
 
with liver digestion media (Invitrogen), each having been prewarmed
 
to 37°C. The 
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digested liver was diced in cold hepatocyte
 
wash media (Invitrogen), passed through an 80 µm nylon
 
mesh (Sefar-America, Depew, NY, USA), and washed an additional
 
three times. Cells were pelleted and 
resuspended in cold Williams E medium
 
containing 10% FBS, 10
–7
 M dexamethasone, 10 µg/ml
 
insulin, 
and 5 µg/ml transferrin. Viability was estimated
 
by the trypan blue exclusion, and only preparations with 
viability
 
in excess of 80% were used for experiments. Cells were plated
 
overnight in 6-well Primaria 
plates (BD Biosciences, San Jose,
 
CA, USA) at a density of 5 x 105 per well. Chondrocytes were isolated 
from fetal ribs and sternums that had been digested in 2mg/mL collagenase P (Roche) for 4 hours at 37
o
C. 
Chondrocytes were centrifuged in 15 mL tubes and cultured as a three-dimensional pellet in DMEM:F12 
supplemented with 10% fetal calf serum. 
 
Glucose, triglyceride, elastase assays: Serum glucose was measured using a One Touch glucose meter. 
Serum triglycerides were measured using a triglyceride determination kit (Sigma) as per the 
manufacturer’s instructions. Elastase inhibition was performed using diluted serum as indicated and a 
fixed concentration of porcine elastase in a fluorescence based activity assay (Invitrogen). 
 
Skeletal preparations: Adult or fetal mice were skinned, eviscerated, and fixed in 95% ethanol. Then 
skeletons were stained by Alizarin red S/Alcian blue and sequentially cleared in 1% potassium hydroxide.   
 
EM analysis: Chondrocytes in either monolayer or 3-D pellet cultures were fixed for electron microscopy 
after culturing for 14 days to allow for matrix deposition. The cells were fixed in 2.5% glutaraldehyde, 
3% paraformaldehyde,
 
with 5% sucrose in 0.1 M sodium cacodylate buffer (pH 7.4).
 
Cells were then 
postfixed in 1% OsO4 in veronal-acetate buffer.
 
The cells were stained in block overnight with 0.5% 
uranyl acetate
 
in veronal-acetate buffer (pH 6.0), dehydrated, and embedded
 
in Spurr’s resin. Sections 
were cut on a Reichert Ultracut
 
E microtome with a Diatome diamond knife at a thickness setting
 
of 50 
20 
 
nm, and stained with 2% uranyl acetate, followed by 0.1%
 
lead citrate. Samples were examined using an 
FEI Tecnai Spirit
 
TEM at 80 KV and imaged with an AMT camera.
 
 
 
Neuronal imaging: Animals were transcardially perfused with cold phosphate buffered saline followed by 
4% paraformaldehyde in 0.1M phosphate buffer. Tissue was postfixed with the same fixative and was 
washed thoroughly with PB. Neural tissue was dissected free and was cryoprotected by sequential 
overnight incubations in 15% and 30% w/v sucrose in 0.1M PB. Tissue was embedded in OCT, frozen 
and cut into 20 micron serial sections on a cryostat. Tissue sections were mounted on slides, and were 
stained with cresyl violet or were immunostained with a panel of antibodies using methods described in 
Barnes et al. Cell 2007. SMI312 anti-neurofilament mAb (Covance Research Products) and Alexa-488 
conjugated goat anti-mouse secondary antibodies were used to visualize axon tracts. Epifluorescence and 
transmitted light images were collected from matched sections from different regions of the brains of 2 
controls and 2 Der2
-/-
. 
Quantitative PCR: Chondrocytes were isolated from embryonic day 18.5 mice. RNA was prepared from 
freshly isolated chondrocytes or from cells that had been cultured for 14 days. RNA extraction was 
performed using Trizol (Invitrogen), and cDNA was synthesized using Superscript II (Invitrogen). 
Quantitative PCR was performed using SYBR green and the following primers: actinF 
AGCACAGCTTCTTTGCAGCTCCTT; actinR CAGCGCAGCGATATCGTCATCCAT; chopF 
ACAGAGCCAGAATAACAGCCGGAA; chopR TGCTTTCAGGTGTGGTGGTGTATG. 
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Table 1 
 
B cell subset   Markers    control  Der2CD19 
Marginal zone B cells  CD19+CD21hiCD23loCD1d+  9.0 +/- 4.2 8.7 +/- 4.7 
Follicular B cells  CD19+CD21+CD23+   61.7 +/- 2.7 60.6 +/- 3.5 
Transitional (T1)  CD23loAA4.4+    12.0 +/- 5.6 10.7 +/- 4.4 
Transitional (T2)  CD23+AA4.1+    10.6 +/- 6.3 8.4 +/- 3.7 
Germinal center B cells  CD19+GL7+    5.6 +/- 2.6 4.2 +/- 1.5 
IgM+IgDlo spleen cells  IgM+IgDlo    21.5 +/- 4.8 21.2 +/- 5.0 
IgM+IgD+ spleen cells  IgM+IgD+    30.6 +/- 10.3 31.8 +/- 6.0 
IgMloIgD+ spleen cells  IgMloIgD+    33.7 +/- 11.3 29.3 +/- 5.7 
CD138+ B220+ spleen cells CD138+B220+    3.1 +/- 1.2 2.0 +/- 1.0 
CD138+ B220lo spleen cells CD138+B220lo    1.5 +/- 0.8 1.1 +/- 0.6 
Pro B cells   B220+CD43+CD19lo   4.9  5.8 +/- 0.4 
Pre B cells   B220+CD43+CD19+   24.2  18.4 +/- 2.2 
Bone marrow plasma cells CD138+B220+    19.5 +/- 1.1 20.1 +/- 4.1 
Peritoneal cavity B-1 cells CD19+B220lo    11.4 +/- 8.5 25.6 +/- 10.5 
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Figure 1: Der2-/- MEFs show impaired protein dislocation. A) RI332-HA transfected MEFs were starved for one hour, 
pulsed with 35S cysteine and methionine for 20 minutes, and chased in non-radioactive media for the indicated times. Cells 
were lysed in NP-40 lysis buffer and immunoprecipitated with anti-HA beads. Samples were analyzed by SDS-PAGE, 
and band intensity was quantified using a phosphoimager. A representative gel is shown on the left. Quantification of 
three independent experiments is shown on the right. B) MEFs were transfected with α1-antitrypsin (α1αT) and Null 
Hong Kong (NHK) plasmids and subjected to pulse-chase analysis as in A. Lysates were immunoprecipitated with an 
antibody to α1-antitrypsin. A representative gel is shown on the left. Quantification of three independent experiments is 
shown on the right. C) MEFs were subjected to pulse-chase analysis as in (A). Lysates were immunoprecipitated with 
anti-MHC I antiserum. 
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Figure 2: Der2-/- cells upregulate members of the dislocation complex and show a constitutive unfolded protein response. 
A) NP-40 lysates from two wild type and four Der2-/- lines of MEFs were immunoblotted using the indicated antibodies. 
B) NP-40 lysates were prepared from MEFs, naïve B cells, freshly isolated hepatocytes, or chondrocytes. Lysates were 
normalized for total protein content, subjected to SDS PAGE, and immunoblotted using the indicated antibodies. 
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Figure 3: Derlin-2 deficiency has no effect on B cells. A) Spleen and bone marrow cells were harvested from Der2CD19  
mice or their cre-negative littermates. B cell subsets were analyzed by flow cytometry. One representative mouse is shown 
for each genotype; means for multiple mice are shown in Table 1. B) B cells were isolated from Der2CD19  mice or their 
cre-negative littermates and cultured for 3 days in media with LPS. Cells were then cultured in cysteine and methionine-
free media for one hour, pulsed with 35S cysteine and methionine for 10 minutes, and chased in non-radioactive media for 
the indicated times. Cells were lysed in NP-40 lysis buffer, immunoprecipitated using anti-IgM antiserum, and analyzed 
by SDS-PAGE. C) Quantification of three independent experiments performed as in (B). D) B cells were harvested from 
wild type, Xbp1CD19, or Der2CD19  mice and cultured in media containing LPS for the indicated number of days. Cells were 
lysed in NP-40 lysis buffer, subjected to SDS-PAGE, and immunoblotted using the indicated antibodies. 
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Figure 4: Derlin-2 deficiency has no effect on liver 
function. A) Adult Der2Alb  mice or their cre-negative 
littermates were fasted overnight and blood glucose levels 
were measured using a glucose monitoring system. B) Adult 
Der2Alb  mice or their cre-negative littermates were fasted 
overnight and serum triglycerides were measured. C) 
Der2Alb  mice or their cre-negative littermates were injected 
intraperitoneally with tunicamycin (1 mg/kg) and body 
weight was monitored over time. Mice were euthanized 
when they reached 80% of initial body weight. D) Serum 
from Der2Alb  mice or their cre-negative littermates was 
subjected to SDS-PAGE and immunoblotted using the 
indicated antibodies. E) Serum from two Der2Alb  mice and 
two littermate controls was added to an elastase activity 
assay to determine the relative levels of inhibitory serum 
anti-serine proteases. F) Der2Alb  mice or their cre-negative 
littermates were fasted or not fasted for 24 hours. Livers 
were perfused with PBS, harvested and lysed in NP-40 lysis 
buffer. Lysates were subjected to SDS-PAGE and 
immunoblotted using the indicated antibodies. 
0 30 60 90 240 0 30 60 90 240
ApoB 48
albumin
wt intracellular Der2∆ intracellular
30 60 90 240 30 60 90 240
Der2∆ mediawt media
0 30 60 90 240 0 30 60 90 240
wt intracellular Der2∆ intracellular
30 60 90 240 30 60 90 240
Der2∆ mediawt mediaA B
C
D
Time (min)
%
 o
f i
ni
tia
l v
al
ue
0
20
40
60
80
100
120
0 100 200 300
control ApoB48
Der2 Albcre+ ApoB48
control albumin
Der2 Albcre+ albumin
Figure 5: Derlin-2 deficiency has no effect on protein 
synthesis in isolated hepatocytes. A) Hepatocytes were 
isolated from Der2Alb  mice or their cre-negative littermates. 
Cells were cultured in cysteine and methionine-free media 
for one hour, pulsed with 35S cysteine and methionine for 20 
minutes, and chased in non-radioactive media for the 
indicated times. Cells were lysed in NP-40 lysis buffer, and 
whole lysates were subjected to SDS-PAGE. B) 
Hepatocytes were treated as in (A) and media fractions were 
collected at each time point to assess secreted proteins. 
Equal volumes of media were subjected to SDS-PAGE. C) 
Hepatocytes treated as in (A) were lysed in NP-40 lysis 
buffer. Lysates were immunoprecipitated using anti-
apolipoprotein B antiserum, and samples were subjected to 
SDS-PAGE. D) Quantification of (C). 
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Figure 6: Whole body deletion of Derlin-2 leads to perinatal lethality 
and cartilage defects. A) A litter containing Der2-/- pups was delivered 
via caesarean section and not permitted to feed for two hours. Serum 
glucose levels were measured. B) One day old pups from a litter 
containing a Der2-/- mouse. Milk spots indicated by arrowheads. C) Body 
weights of Der2-/- mice and littermate controls at various ages. Der2-/- 
mice did not survive beyond 52 weeks. Der2-/- male and female mice did 
not vary significantly in their weights. D) Skeletons of a nine-month old 
Der2-/- and wild type control mouse were harvested and stained with 
Alizarin red and Alcian blue. Note the bottom three pairs of ribs connect 
to a single sternebrae in the Der2-/- mouse, indicating fusion of the 3rd 
and 4th sternebrae (arrow). Der2-/- rib cartilage is punctuated with linear 
calcifications (open arrowheads). E) Skeletons were harvested from E 
day 18.5 Der2-/- and wild type embryos and stained with Alizarin red and 
Alcian blue. Note the ossification center (arrow) between the 3rd and 4th 
sternebrae is smaller in Der2-/- mice. F) Hematoxylin and eosin staining 
of rib cartilage from adult mice (20x magnification). G) Sections were 
prepared as in (F). Arrows indicate chondrocytes with eosinophilic 
cytoplasmic inclusions in adult Der2-/- mice.  
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Figure 7: Der2-/- chondrocytes show intracellular retention of 
extracellular matrix proteins. A) Chondrocytes were isolated from wild 
type or Der2-/- embryonic day 18.5 mice were maintained in 3D pellet 
culture for 8 days prior to fixation, sectioning and analysis by EM. Both 
samples contained similar amounts of extracellular collagen fibrils. Note 
the distended ER in Der2-/- chondrocytes. N, nucleus; M, mitochondrion; 
C, collagen fibers. B) Chondrocytes were cultured as in (A) for 1 day or 
8 days. Cells were analyzed by electron microscopy and scored as dilated 
or not dilated. Total number of cells (n) counted per group is indicated 
above each bar. C) Protein lysates were harvested from chondrocytes that 
had been cultured for 8 days. Lysates were analyzed by SDS-PAGE and 
immunoblotted using the indicated antibodies. Note the increased CHOP 
expression in Der2-/- chondrocytes. D) RNA was isolated from freshly 
isolated embryonic day 18.5 chondrocytes or chondrocytes that had been 
maintained in culture for 2 weeks, and cDNA was prepared. Quantitative 
PCR was performed using primers specific for Chop and normalized to 
β-actin. *, p<0.005. 
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Supplemental Figure 1: Generation of Derlin-2 floxed mouse. A) Schematic diagram of the Derlin-2 genomic locus, 
targeting construct and genomic locus of the resulting Der2-/- mouse after cre-mediated deletion. B) Genomic DNA was 
prepared from two lines of targeted ES cells or control ES cells and Southern blotted using the probe indicated in (A). 
Correct targeting of the Derlin-2 locus is indicated by the presence of a 5050 Kb band. C) NP-40 lysates were prepared 
from the indicated tissues of a Der2-/- mouse or littermate control. Samples were subjected to SDS-PAGE and 
immunoblotted for Derlin-2. 
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Supplemental Figure 2: Nissl and neurofilament staining demonstrate that major axon tracts and the gross structure of 
the brain are intact at postnatal day 0 in the Der2-/- (C,D,G,H) as compared to a littermate control (A,B,E,F). Serial 
sections from the level of the optic tract (A-D) or from Spinal trigeminal nucleus interpolaris (E-H) were stained as 
indicated. Immunostaining for activated caspase-3 revealed no evidence of increased apoptosis in the central nervous 
system of Der2-/- animals (not shown). Peripheral nerves and spinal ganglia were also not grossly affected by the loss of 
Derlin-2. Phrenic innervation of the diaphragm was normal as were the appearance of neuromuscular junctions as 
determined by whole mount immunohistochemistry of diaphragm muscle (data not shown). 
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Supplemental Figure 3: Chondrocytes from wild type or Der2-/- embryonic day 18.5 mice were maintained in three 
dimensional culture for 8 days and analyzed by electron microscopy. Shown are collagen fibrils secreted into the 
extracellular matrix (49,000x magnification). 
